Video
Dealmaker’s Diary: Don’t Let This Common Metric Cost You Money
Traditional valuation metrics can mislead investors. Here’s how to look beyond simple ratios for better returns.
Buy This, Not That: This Automaker’s 6% Dividend Is Too Good to Pass Up
While one auto giant trades near highs, another offers an attractive dividend and ideal entry point.
Monday Takeaways: A Triple Threat of Tariffs, Tech, and Trading Pressure
Earnings season is heating up… as is Trump’s tariff war. Shah knows how to play it safe…
Dealmaker’s Diary: A Double Dose of Tickers
By reader request, Alpesh rates a cutting-edge biotech with 232% potential upside and a semiconductor giant with low volatility.
Buy This, Not That: What to Do After Nvidia’s Historic Drop
The market’s top semiconductor stock lost nearly $600 billion in market cap in a single day. But the chart tells us what we need to know.
Monday Takeaways: Chinese AI Rocks Markets
A new Chinese AI breakthrough sends tech stocks tumbling, just as we face a crucial week of mega-cap earnings and Fed decisions.
Dealmaker’s Diary: Data Over Drama Gives This Stock 50% Upside
While headlines focus on insurance sector challenges, one company’s fundamentals suggest a very different narrative ahead.
Buy This, Not That: Which Oil Services Company Will Win With “Drill, Baby, Drill”?
With Trump’s “drill, baby, drill” energy policy returning, here’s which oil services giant stands to benefit most.
Dealmaker’s Diary: The Contrarian Play That Defies Market Logic
Despite industry headwinds and natural disasters, this $4.6 billion insurance company shows surprising strength. Our proprietary GVI analysis reveals why market fear creates your opportunity.
Buy This, Not That: The Athletic Giant Tunning Away With the Competition
As fitness resolutions meet market realities, which athletic sneaker giant offers the better investment opportunity?